Complement components, C3 and C4, and the metabolic syndrome

M Copenhaver, CY Yu, RP Hoffman - Current diabetes reviews, 2019 - ingentaconnect.com
Introduction: Increased systemic inflammation plays a significant role in the development of
adult cardiometabolic diseases such as insulin resistance, dyslipidemia, atherosclerosis …

The complement system in human cardiometabolic disease

E Hertle, CDA Stehouwer… - Molecular immunology, 2014 - Elsevier
The complement system has been implicated in obesity, fatty liver, diabetes and
cardiovascular disease (CVD). Complement factors are produced in adipose tissue and …

Complement C3: an emerging risk factor in cardiometabolic disease

E Hertle, MMJ Van Greevenbroek, CDA Stehouwer - Diabetologia, 2012 - Springer
C3 is the central component of the complement system and activation of C3 via any of the
three major activation pathways—the classical, the lectin and the alternative pathways …

The role of complement system in adipose tissue-related inflammation

SI Vlaicu, A Tatomir, D Boodhoo, S Vesa… - Immunologic …, 2016 - Springer
As the common factor linking adipose tissue to the metabolic context of obesity, insulin
resistance and atherosclerosis are associated with a low-grade chronic inflammatory status …

The role of complement factor C3 in lipid metabolism

A Barbu, OA Hamad, L Lind, KN Ekdahl, B Nilsson - Molecular immunology, 2015 - Elsevier
Abundant reports have shown that there is a strong relationship between C3 and C3a-
desArg levels, adipose tissue, and risk factors for cardiovascular disease, metabolic …

Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study)

MMJ van Greevenbroek, M Jacobs… - International journal of …, 2012 - Elsevier
BACKGROUND: Complement C3 is an emerging risk factor for coronary heart disease
(CHD) and is particularly increased in the metabolic syndrome. A direct effect of smoking on …

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population

A Onat, G Hergenç, G Can, Z Kaya, H Yüksel - Metabolism, 2010 - Elsevier
We studied whether serum complement C3 (C3) is an independent determinant of incident
cardiometabolic risk (coronary heart disease [CHD], metabolic syndrome [MetS], and type 2 …

The emerging role of complement C3 as a biomarker of insulin resistance and cardiometabolic diseases: preclinical and clinical evidence

F Ursini, L Abenavoli - Reviews on recent clinical trials, 2018 - ingentaconnect.com
Background: An intricate network of reciprocal interactions between adipose tissue and
immune system have been largely demonstrated, leading to the well-accepted concept of …

Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study

G Engström, B Hedblad, L Janzon… - European Journal of …, 2007 - academic.oup.com
Background Complement factor C3 and C4 have been associated with atherosclerosis and
cardiovascular risk factors. This study explored whether plasma levels of C3 and C4 are risk …

C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors

B Nilsson, OA Hamad, H Ahlström… - European journal of …, 2014 - Wiley Online Library
Background In several reports, C3 and C4 have been linked to diabetes and cardiovascular
disease (CVD). Here, we investigate this link and the degree of C3 activation in elderly …